Home haemodialysis (HD) offers several advantages over conventional in-centre 3-times-weekly HD which have been summarised in recent reviews [1,2]. Among them are better preservation of health-related quality of life, treatment flexibility, facilitation of life rehabilitation and improved outcomes, including increased survival rates and reduced hospitalisations [3–5]. Intensive home HD has been shown to achieve outcomes comparable to, or even better than, those achieved with cadaveric kidney transplantation for marginal kidney donors [6–8].
